PEP-ICD LTD
Company number 14837509 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
PEP-ICD LTD - Analysis Report
Company Number: 14837509
Analysis Date: 2025-07-29 20:06 UTC
Financial Health Assessment of PEP-ICD LTD
1. Financial Health Score:
Grade: D
Explanation: The company is in its infancy stage (incorporated 2023) and currently shows net liabilities and negative net current assets, which are symptoms of financial distress. The absence of profitability and employees, combined with a negative equity position, signals early financial challenges. However, this is not uncommon for a newly incorporated micro-entity still in the setup phase.
2. Key Vital Signs:
| Metric | Value (£) | Interpretation |
|---|---|---|
| Net Current Assets | -1,520 | Negative working capital indicates the company’s short-term debts exceed its short-term assets — a "symptom of liquidity strain." |
| Net Assets (Equity) | -1,519 | Negative equity ("balance sheet deficit") suggests liabilities exceed assets, indicating an "unhealthy financial position." |
| Employees | 0 | No employees yet; likely early stage or founder-run, implying limited operational capacity currently. |
| Account Category | Micro | Minimal filing thresholds and requirements; company is small-scale and early in its lifecycle. |
| Profit & Loss Account | Not filed | No reported profit/loss data; limits insight into operational performance ("absence of metabolic data"). |
| Directors & Ownership | Two directors, each owning 25-50% shares | Concentrated control, typical for start-ups; aligned interests but also risk if founders face challenges. |
3. Diagnosis:
PEP-ICD LTD is a newly formed micro private limited company specializing in "Other professional, scientific and technical activities not elsewhere classified," likely energy management consultancy as per website info.
Symptoms of distress:
- The company’s balance sheet shows a small but negative net asset position (£-1,519), indicating that at this early stage it has more liabilities than assets. This is a classic early "cash flow and funding deficit" symptom common in start-ups.
- Negative net current assets (£-1,520) means immediate obligations exceed readily available assets, raising short-term liquidity concerns.
- No employees suggest minimal operating activity or reliance on directors/founders only.
- Lack of P&L information restricts assessment of profitability or cash generation.
- The business remains active and has timely filings, which is positive, showing compliance and no immediate regulatory distress.
Underlying cause:
The financial "symptoms" primarily reflect the start-up phase where initial costs and liabilities (possibly setup costs or creditors) exceed assets and operational income. The company may be relying on director funding or loans, and has yet to generate positive cash flow or build equity.
4. Recommendations:
To improve financial wellness and move from "symptoms of distress" to "healthy operations," the company should consider:
- Strengthen liquidity: Seek additional working capital injections (equity or short-term loans) to cover liabilities and avoid cash flow crises.
- Revenue generation: Accelerate client acquisition and service delivery to start generating operational income and move towards profitability.
- Cost management: Monitor and control overheads carefully; consider outsourcing or minimal staffing until revenues stabilize.
- Financial monitoring: Prepare and file a profit & loss account to track operational performance and inform management decisions.
- Build equity: Retain earnings or inject funds to restore positive net assets and build a stronger balance sheet.
- Governance: Directors should maintain clear financial oversight and ensure tax and filing compliance to avoid penalties.
- Future planning: Develop a detailed financial forecast and business plan to secure investor confidence and guide growth.
Medical Analogy Summary:
PEP-ICD LTD is a newborn patient showing early "signs of weakness" such as negative cash reserves and a deficit in net worth. This is typical of start-ups but requires quick intervention—like a doctor prescribing rest and nourishment—to stabilize and grow. Without sufficient funding ("vitamin injections") and income ("food for growth"), the company risks "financial malnutrition," which could threaten its survival.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.